AbCellera Biologics (ABCL) Proxy Filing summary

Executive summary

• Annual meeting set for June 12, 2025 at 9:00 a.m. Pacific Time, live online; stockholders of record as of April 15, 2025 are eligible to vote.

• Board recommends voting FOR proposals 1, 2 and 3.

Voting matters and shareholder proposals

• Proposal 1 seeks election of two Class II directors; Proposal 2 seeks ratification of KPMG LLP for FY ending Dec. 31, 2025; Proposal 3 is an advisory say-on-pay vote.

• Proposal 4 permits consideration of other business properly brought before the meeting or any adjournment or postponement.

Board of directors and corporate governance

• Carl L. G. Hansen and Michael Hayden are nominees for Class II director terms through the 2028 annual meeting and until successors are elected and qualified.